What is the main problem that Endoluminal Vacuum Therapy (EVT) is designed to address?

Anastomotic leaks are a significant complication following ileal pouch-anal anastomosis (IPAA). These leaks can lead to serious problems, impacting how well the pouch functions and potentially causing the pouch to fail. Traditionally, these leaks required surgical interventions to fix, but a less invasive method, Endoluminal Vacuum Therapy (EVT), is showing promise.

How does Endoluminal Vacuum Therapy (EVT) work to heal IPAA leaks?

Endoluminal Vacuum Therapy (EVT) involves placing a special sponge, the Endosponge®, directly into the anastomotic leak cavity. This sponge is linked to a vacuum suction bottle that creates continuous negative pressure. This negative pressure helps by draining fluids and debris, collapsing the leak cavity, and stimulating the growth of healthy granulation tissue. The goal is to close the leak and promote healing without the need for additional surgeries.

What is the role of the Endosponge® in Endoluminal Vacuum Therapy (EVT)?

The Endosponge® is a key part of Endoluminal Vacuum Therapy (EVT). It's a specialized, open-pored polyurethane sponge placed directly into the anastomotic leak. Its purpose is to facilitate healing by removing fluids, reducing the size of the leak cavity, and encouraging the formation of granulation tissue. The Endosponge® device is regularly replaced to ensure the effectiveness of the treatment.

How were patients monitored during Endoluminal Vacuum Therapy (EVT)?

Researchers monitored patients closely during Endoluminal Vacuum Therapy (EVT). The Endosponge® device was replaced every 48-72 hours. Patients also underwent weekly pouchoscopy examinations for the first month, then monthly. Antibiotics were given as needed. This careful monitoring allowed doctors to track the healing progress, assess the effectiveness of the Endoluminal Vacuum Therapy, and ensure no additional surgical procedures were necessary.

What are the potential benefits of using Endoluminal Vacuum Therapy (EVT) for IPAA leak management?

The pilot study suggests that Endoluminal Vacuum Therapy (EVT) can be an effective primary treatment for anastomotic leaks after ileal pouch-anal anastomosis (IPAA). This could reduce the need for more invasive surgeries and improve patient outcomes. While the study was small, the positive results indicate that Endoluminal Vacuum Therapy (EVT) is a valuable tool in managing complications related to IPAA.

Visualization of endoluminal vacuum therapy healing an anastomotic leak.

The Future of IPAA Treatment: Is Endoluminal Vacuum Therapy the Answer?

Soraya Malik in Health & Wellness October 2026 • 4 min read.

"A pilot study reveals promising results for endoluminal vacuum-assisted therapy in treating anastomotic leaks after ileal pouch-anal anastomosis (IPAA), potentially reducing the need for surgery and improving patient outcomes."

Anastomotic leaks following ileal pouch-anal anastomosis (IPAA) can lead to significant complications, impacting functional outcomes and potentially causing pouch failure. Traditionally, treatment has involved surgical interventions to address these leaks, but a new approach is gaining traction.

A recent pilot study published in Techniques in Coloproctology explores the use of endoluminal vacuum-assisted therapy (EVT) as a primary treatment for anastomotic leaks after IPAA. The study investigates whether EVT alone can effectively manage these leaks without the need for additional surgical procedures.

This article will delve into the findings of the study, examining the methodology, results, and implications for the future of IPAA leak management. By understanding this innovative approach, patients and healthcare professionals can make more informed decisions about treatment options and improve patient outcomes.

AI Search Multiple angles on this topic

Stats & Impact

The Impact of IPAA Leaks

Chronic anastomotic leakage is reported as the most common cause of pouch failure after restorative proctocolectomy with ileal pouch–anal anastomosis for ulcerative colitis. Leaks occur most commonly at the IPAA, followed by the tip of the “J” and the pouch body. Early diagnosis and treatment are important because the timing and size of the leak, along with associated abscesses and strictures, can affect management and outcomes.

Standard Approach

A Complex, Individualized Approach

Management of pouch leaks after IPAA remains a complex process that often requires an individualized approach. Anastomotic disruption can be life-threatening and potentially functionally devastating, so prompt recognition and careful management are emphasized. In patients with inflammatory bowel disease, the difficult IPAA operation is often performed in two or three phases to help prevent anastomotic leakage.

History

From IPAA to Leak Prevention

Ileal-anal pouch surgery has developed alongside efforts to manage its complications. A 2019 review identifies pouchitis as the most common complication of IPAA and discusses strategies intended to prevent acute leaks from becoming chronic leaks. This focus on preventing chronic leakage reflects the long-term consequences that leaks can have after pouch construction.

How Does Endoluminal Vacuum Therapy (EVT) Work for IPAA Leaks?

Visualization of endoluminal vacuum therapy healing an anastomotic leak.

Endoluminal vacuum therapy involves placing a specialized sponge, known as Endosponge®, directly into the anastomotic leak cavity. This open-pored polyurethane sponge is connected to a vacuum suction bottle, which creates continuous negative pressure within the cavity. This negative pressure facilitates several key processes:

The study enrolled consecutive patients with anastomotic leaks after IPAA between March 2016 and March 2017. Following diagnosis of a leak, the Endosponge® device was positioned within the gap and replaced regularly until the cavity reduced in size and was covered with healthy, granulating tissue. Pouchoscopy, a visual examination of the pouch, was performed weekly for the first month and then monthly to monitor progress. Importantly, no additional surgical procedures were performed during this treatment period.

Fluid Drainage: The vacuum suction effectively removes contaminated fluids and debris from the leak cavity, reducing the risk of infection and promoting a cleaner environment for healing.
Cavity Reduction: The continuous suction helps to collapse the leak cavity, gradually reducing its size over time.
Granulation Tissue Formation: The negative pressure stimulates the growth of healthy granulation tissue, which fills the cavity and promotes closure of the leak.

AI Search Multiple angles on this topic

Latest Research

Evolving Endoluminal Vacuum Therapy

Recent reports describe modified endoluminal vacuum therapy as a treatment for rectal anastomotic leaks, with the anastomotic opening almost completely repaired after three sessions in three patients. The E-VAC system uses an Endosponge device and is described as promoting recovery through hyperemia, reduced bacterial colonization, prevention of tissue edema, and granulation of the wound. E-VAC has also demonstrated success for anastomotic leaks after IPAA, including use to clean a presacral cavity before transanal closure of the defect after two to three applications.

Comparison

Staged IPAA Comparisons

A tertiary-care IBD center comparison reported that morbidity and anastomotic leak rates did not differ from those previously reported for transanal IPAA series. The study included a variable proportion of multistage procedures, making staging an explicit part of the comparison. Its findings therefore support comparison of leak outcomes across different staged IPAA approaches rather than establishing a universal advantage for one staging strategy.

Researchers closely monitored the patients throughout the EVT process. The Endosponge® device was replaced every 48-72 hours until the cavity was deemed clean and covered with granulation tissue, indicating that it could heal effectively through secondary intention. Antibiotic treatment was administered at the time of diagnosis and continued as needed based on blood tests and clinical assessment. Patients underwent weekly outpatient endoscopy for the first month and monthly thereafter until the leak was confirmed to be completely closed.

A Promising Step Forward in IPAA Leak Management

The results of this pilot study offer a promising outlook for the use of Endosponge® therapy in managing anastomotic leaks after IPAA. The study suggests that EVT can be an effective primary treatment option, potentially reducing the need for more invasive surgical interventions. However, it is important to acknowledge that this was a pilot study with a limited number of patients, but EVT shows potential as a valuable tool in the management of this challenging complication.